We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Four new Commissioners will join the Commission on Human Medicines (CHM) on 1 May 2021.
The benefits of vaccination continue to outweigh any risks but the MHRA advises careful consideration be given to people who are at higher risk of specific types of blood clots because of their medical condition.
Following suspensions by some countries of the COVID-19 Vaccine AstraZeneca over suspected blood clots, the MHRA confirms that the benefits of the vaccine in preventing COVID-19 far outweigh the risks. People should still go…
The MHRA is committed to speeding up access to innovative new medicines for patients.
A pilot project that puts patient involvement at the heart of clinical trials and medicine development has been launched by the Medicines and Healthcare products Regulatory Agency (MHRA).
It is suspected that the pills were being sold through illegally operating websites
Future vaccine modifications that respond to new variants of coronavirus to be made available quickly to UK recipients, without compromising on safety, quality or effectiveness.
Balkeet Singh Khaira sold hundreds of thousands of Class C drugs from his mother's pharmacy
The Innovative Licensing and Access Pathway (ILAP) aims to reduce the time to market for innovative medicines
The public has until 5 March to respond to the consultation on the potential reclassification of desogestrel to a pharmacy medicine.
The Consortium brings together 16 leading organisations, spanning the NHS, regulators, and leading third sector and charitable organisations
Data published from UK’s independent medicines regulator confirms approved vaccines meet strict regulatory standards for safety
The National Institute for Biological Standards and Control will carry out independent testing in the UK for any potential COVID-19 vaccines.
The vaccine has been approved after meeting the required safety, quality and effectiveness standards.
The Access Consortium regulatory authorities have pledged our collective support in countering the COVID-19 global pandemic.
Women receiving treatment for epilepsy are being urged to discuss with a healthcare professional the right treatment for them if they anticipate becoming pregnant even sometime in the future, following a safety review.
The Medicines and Healthcare products Regulatory Agency (MHRA) today, 1 January 2021, formally starts the Innovative Licensing and Access Pathway (ILAP).
The new vaccine has been approved after meeting the required safety, quality and effectiveness standards.
An application for exceptional use of a COVID-19 rapid test, to be used by members of the public, has today been approved by the Medicines and Healthcare products Regulatory Agency (MHRA).
MHRA Chief Executive Dr June Raine explains the process behind the Agency's approval of the Pfizer/BioNTech vaccine
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).